24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral... — RxCUI 2709470
RxNorm drug concept · Semantic clinical drug
RxCUI 2709470
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
12 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2709470
Official name24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmetFORMIN hydrochloride 1000 MG / SITagliptin phosphate 100 MG 24HR Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped12
Reported Medicaid activity (SDUD)46,097 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sitagliptin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sitagliptin helps your body manage blood sugar more effectively by keeping certain gut hormones active longer after you eat. Those hormones tell your pancreas to release more insul...
- What exactly does sitagliptin do — and will it cure my diabetes?
- On its own, sitagliptin is very unlikely to cause low blood sugar — that's actually one of its advantages. The reason is that it only kicks in when your blood sugar is already elev...
- Can sitagliptin make my blood sugar go too low?
🕸️ Concept Web — How 24 HR metformin hydrochloride 1000 MG / sitaglip... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral Tablet
RxCUI 2709470 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Metformin
6809IN -
Sitagliptin
593411IN -
Metformin / sitagliptin
729717MIN -
Metformin hydrochloride
235743PIN -
Sitagliptin phosphate
621590PIN
-
Metformin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Janumet
1372738BN
-
Janumet
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metformin / sitagliptin Extended Release Oral Tablet
1243826SCDF -
Metformin hydrochloride / sitagliptin phosphate Extended Release Oral Tablet
2709469SCDFP -
Metformin / sitagliptin Oral Product
1161607SCDG -
Metformin / sitagliptin Pill
1161608SCDG -
Metformin hydrochloride / sitagliptin phosphate Oral Product
2709467SCDGP -
Metformin hydrochloride / sitagliptin phosphate Pill
2709468SCDGP -
Metformin / sitagliptin Extended Release Oral Tablet [Janumet]
1243839SBDF -
Metformin hydrochloride / sitagliptin phosphate Extended Release Oral Tablet [Janumet]
2709473SBDFP - +5 more in this family
-
Metformin / sitagliptin Extended Release Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metformin hydrochloride 1000 MG
860995SCDC -
Sitagliptin phosphate 100 MG
2709466SCDC -
24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral Tablet [Janumet]
1243833SBD -
Metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG [Janumet]
2709472SBDC
-
Metformin hydrochloride 1000 MG
Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metformin hydrochloride 1000 MG
SCDC · 860995 -
Sitagliptin phosphate 100 MG
SCDC · 2709466 -
Metformin / sitagliptin Extended Release Oral Tablet
SCDF · 1243826 -
Metformin hydrochloride / sitagliptin phosphate Extended Release Oral Tablet
SCDFP · 2709469 -
Metformin / sitagliptin Oral Product
SCDG · 1161607 -
Metformin / sitagliptin Pill
SCDG · 1161608 -
Metformin hydrochloride / sitagliptin phosphate Oral Product
SCDGP · 2709467 -
Metformin hydrochloride / sitagliptin phosphate Pill
SCDGP · 2709468
Brand-Name Concepts
-
24 HR metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG Extended Release Oral Tablet [Janumet]
SBD · 1243833 -
Metformin hydrochloride 1000 MG / sitagliptin phosphate 100 MG [Janumet]
SBDC · 2709472 -
Metformin / sitagliptin Extended Release Oral Tablet [Janumet]
SBDF · 1243839 -
Metformin hydrochloride / sitagliptin phosphate Extended Release Oral Tablet [Janumet]
SBDFP · 2709473 -
Janumet Oral Product
SBDG · 1167810 -
Janumet Pill
SBDG · 1167811 -
Janumet
BN · 1372738
📦 FDA Products & Package NDCs
3 products · 12 package NDCs
12 package NDCs map to RxCUI 2709470 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00006-0078-28 | 2 BOTTLE in 1 CARTON (0006-0078-28) / 14 TABLET, FILM COATE... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0078-61 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0078-62 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0078-82 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0080-28 | 2 BOTTLE in 1 CARTON (0006-0080-28) / 14 TABLET, FILM COATE... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0080-61 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0080-62 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0080-82 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0081-14 | 2 BOTTLE in 1 CARTON (0006-0081-14) / 7 TABLET, FILM COATED... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0081-31 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0081-54 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006-0... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
| 00006-0081-82 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0006... | JANUMET XR | Merck Sharp & Dohme LLC | 2012-02-02 |
Observed labelers:
Merck Sharp & Dohme LLC (12)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.